Texas Yale Capital Corp’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,300	Closed	-$459K	–	462
2022 Q4	$459K	Buy	11,300 +400	+4%	+$16.3K	0.03%	334
2022 Q3	$712K	Buy	10,900 +900	+9%	+$58.8K	0.05%	269
2022 Q2	$608K	Buy	+10,000	New	+$608K	0.04%	285